Vectura Group plc/ GB00BKM2MW97 /
2021-10-28 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
1.7700USD | - | 150 Turnover: - |
-Bid Size: - | -Ask Size: - | 1.7700 | 1.7700 |
GlobeNewswire
08-01
Aurora Cannabis and Vectura Fertin Pharma, Inc. announce commercial collaboration
GlobeNewswire
2021-11-11
Aerami Therapeutics Appoints Darlene Deptula-Hicks to its Board of Directors
GlobeNewswire
2021-08-25
Aerami Therapeutics Announces Orphan Drug Designation for Imatinib for the Treatment of Pulmonary Ar...
GlobeNewswire
2021-07-19
RYAH Group Partners with the University of Milan to Develop Conversion Measurement Standards for Dry...
GlobeNewswire
2021-06-24
Aerami Therapeutics Initiates Dosing in Phase 1 Trial of AER-901, Its Proprietary Inhaled Imatinib f...
GlobeNewswire
2021-02-09
Hangzhou Chance Pharmaceuticals Expands Pipeline with In-Licensing of AER901 from Aerami Therapeutic...
GlobeNewswire
2021-02-09
Aerami Therapeutics Signs License Agreement with Hangzhou Chance Pharmaceuticals Co. Ltd. for Aerami...
GlobeNewswire
2020-06-08
Aerami Therapeutics Signs a Global License Agreement with Vectura Group, Adding an Inhaled Therapy f...
GlobeNewswire
2019-10-30
Dry Powder Inhaler Devices Device Pipeline Study 2019: Analysis of Devices under Development, Compan...
GlobeNewswire
2019-09-10
Vectura Group plc: Proposed Special Dividend and Share Consolidation, Share Buyback Programme and Di...
GlobeNewswire
2019-08-30
Global Smart Inhalers Market Set to Exceed $1.4 Billion by 2026, Growing at a CAGR of 58.4% During 2...
GlobeNewswire
2019-07-17
Vectura confirms R&D investment priorities, announces a proposed £50 million capital return and a pr...
GlobeNewswire
2019-02-11
Global Smart Inhalers Market Report 2019: Size, Market Share, Application Analysis, Regional Outlook...
GlobeNewswire
2018-12-17
Chronic Respiratory Disease Drug Development Pipeline Review, 2018: Therapeutics Under Development a...
GlobeNewswire
2018-09-25
Dance Biopharm Holdings announces the appointment of Anne Whitaker as Chief Executive Officer